Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKN2301 in pediatric influenza
NCT07357051Phase 3Recruiting
- Sponsor
- Joincare Pharmaceutical
- Start
- Nov 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Joincare Pharmaceutical. Started Nov 2025; status: recruiting.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07357051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357051.